Roche Molecular Systems Business Systems Analyst Salaries in Tampa, FL
The average Roche Molecular Systems Business Systems Analyst in Tampa, FL earns an estimated $64,356 annually, which includes an estimated base salary of $55,131 with a $9,225 bonus. Roche Molecular Systems' Business Systems Analyst compensation is $19,114 less than the US average for a Business Systems Analyst. Business Systems Analyst salaries at Roche Molecular Systems in Tampa, FL can range from $36,000 - $88,500.
In Tampa, FL, The Operations Department at Roche Molecular Systems earns $1,310 more on average than the Business Development Department.
Last updated a year ago.
- $55,131
- avg. base
- $9,225
- avg. bonus
Business Systems Analyst Salaries at Roche Molecular Systems
In Tampa, FL, Business Systems Analysts earn $3,527 more than Office Managers, and $13,895 less than Operations Managers.
Compensation at Roche Molecular Systems by Department
In Tampa, FL, The Operations Department averages $1,310 more than the Business Development Department, and $4,645 less than the Product Department
Business Systems Analyst Compensation by Gender (All Companies)
The average female Business Systems Analyst at companies similar size to Roche Molecular Systems reported making $89,933, while the average male Business Systems Analyst at similar sized companies reported making $93,781.
Business Systems Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Systems Analyst at companies similar size to Roche Molecular Systems reported making $115,000, while the average African American/Black Business Systems Analyst at similar sized companies reported making $75,705.
How Business Systems Analysts at Roche Molecular Systems Rate Their Compensation
The majority of Business Systems Analysts at Roche Molecular Systems believe they're compensated fairly. 100% of Business Systems Analysts at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
